PAHC
PHIBRO ANIMAL HEALTH CORP
Overview
Phibro Animal Health Corporation develops, manufactures and markets approximately 800 product lines across animal health, mineral nutrition and specialty ingredients for industrial applications.
PHIBRO ANIMAL HEALTH CORP is a Healthcare company operating in Drug Manufacturers - Specialty & Generic with a $1.26B market cap.
Most recent reported earnings: Q2 FY2026 (Aug 25, 2026).
21 earnings calls indexed on Spoken Alpha.
Behavioral analysis
Management language signature
Disclosures
Investor Relations
Extracted from SEC 10-K filing, 2026-06-21.
Transcripts
Recent earnings calls
Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.
- Q1 FY2026Earnings2025-11-065 Q&A exchanges
- Q4 FY2025Earnings2025-08-286 Q&A exchanges
- Q3 FY2025Earnings2025-05-105 Q&A exchanges
- Q2 FY2025Earnings2025-02-065 Q&A exchanges
- Q1 FY2025Earnings2024-11-087 Q&A exchanges
- Q4 FY2024Earnings2024-08-297 Q&A exchanges
- Q3 FY2024Earnings2024-05-108 Q&A exchanges
- Q2 FY2024Earnings2024-02-0816 Q&A exchanges
- Q1 FY2024Earnings2023-11-1018 Q&A exchanges
- Q4 FY2023Earnings2023-08-317 Q&A exchanges
- Q3 FY2023Earnings2023-05-067 Q&A exchanges
- Q2 FY2023Earnings2023-02-098 Q&A exchanges
- Q1 FY2023Earnings2022-11-139 Q&A exchanges
- Q4 FY2022Earnings2022-08-257 Q&A exchanges
- Q3 FY2022Earnings2022-05-083 Q&A exchanges
- Q2 FY2022Earnings2022-02-1010 Q&A exchanges
- Q1 FY2022Earnings2021-11-0511 Q&A exchanges
- Q4 FY2021Earnings2021-08-265 Q&A exchanges
- Q3 FY2021Earnings2021-05-0915 Q&A exchanges
- Q2 FY2021Earnings2021-02-0518 Q&A exchanges
- Q1 FY2021Earnings2020-11-057 Q&A exchanges
History
Earnings history
- Q2 FY20262026-08-25EPS— vs $0.73—Rev— vs ——EODHD
- Q1 FY20262026-05-05EPS$0.76 vs $0.71+7.0%Rev$383.5M vs ——EODHD
- Q4 FY20252026-02-03EPS$0.87 vs $0.67+29.8%Rev$373.9M vs ——EODHD
- Q3 FY20252025-05-06EPS$0.63 vs $0.52+21.1%Rev$347.8M vs ——EODHD
- Q2 FY20252025-02-04EPS$0.54 vs $0.45+20.0%Rev$309.3M vs ——EODHD
- Q1 FY20252024-11-05EPS$0.17 vs $-0.04+100.0%Rev$260.4M vs ——EODHD
- Q4 FY20242024-08-27EPS$0.41 vs $0.33+24.2%Rev$273.2M vs ——EODHD
- Q3 FY20242024-05-07EPS$0.31 vs $0.29+6.9%Rev$263.2M vs ——EODHD
- Q2 FY20242024-02-06EPS$0.33 vs $0.28+17.9%Rev$249.9M vs ——EODHD
- Q1 FY20242023-11-07EPS$0.14 vs $0.23-39.1%Rev$231.3M vs ——EODHD
- Q4 FY20232023-08-29EPS$0.38 vs $0.380.0%Rev$255.0M vs ——EODHD
- Q3 FY20232023-05-02EPS$0.29 vs $0.34-14.7%Rev$245.7M vs ——EODHD
- Q2 FY20232023-02-07EPS$0.34 vs $0.30+13.3%Rev$244.6M vs ——EODHD
- Q1 FY20232022-11-08EPS$0.21 vs $0.27-22.2%Rev$232.5M vs ——EODHD
- Q4 FY20222022-08-23EPS$0.36 vs $0.38-5.3%Rev$255.3M vs ——EODHD
- Q3 FY20222022-05-03EPS$0.33 vs $0.35-5.7%Rev$239.6M vs ——EODHD
- Q2 FY20222022-02-08EPS$0.37 vs $0.33+12.1%Rev$232.7M vs ——EODHD
- Q1 FY20222021-11-01EPS$0.25 vs $0.29-13.8%Rev$214.7M vs ——EODHD
- Q4 FY20212021-08-24EPS$0.32 vs $0.31+3.2%Rev$220.3M vs ——EODHD
- Q3 FY20212021-05-05EPS$0.34 vs $0.32+6.3%Rev$211.7M vs ——EODHD
| Period | Reported | EPS actual | EPS consensus | EPS surprise | Revenue actual | Revenue consensus | Rev. surprise | Source |
|---|---|---|---|---|---|---|---|---|
| Q2 FY2026 | 2026-08-25 | — | $0.73 | — | — | — | — | EODHD |
| Q1 FY2026 | 2026-05-05 | $0.76 | $0.71 | +7.0% | $383.5M | — | — | EODHD |
| Q4 FY2025 | 2026-02-03 | $0.87 | $0.67 | +29.8% | $373.9M | — | — | EODHD |
| Q3 FY2025 | 2025-05-06 | $0.63 | $0.52 | +21.1% | $347.8M | — | — | EODHD |
| Q2 FY2025 | 2025-02-04 | $0.54 | $0.45 | +20.0% | $309.3M | — | — | EODHD |
| Q1 FY2025 | 2024-11-05 | $0.17 | $-0.04 | +100.0% | $260.4M | — | — | EODHD |
| Q4 FY2024 | 2024-08-27 | $0.41 | $0.33 | +24.2% | $273.2M | — | — | EODHD |
| Q3 FY2024 | 2024-05-07 | $0.31 | $0.29 | +6.9% | $263.2M | — | — | EODHD |
| Q2 FY2024 | 2024-02-06 | $0.33 | $0.28 | +17.9% | $249.9M | — | — | EODHD |
| Q1 FY2024 | 2023-11-07 | $0.14 | $0.23 | -39.1% | $231.3M | — | — | EODHD |
| Q4 FY2023 | 2023-08-29 | $0.38 | $0.38 | 0.0% | $255.0M | — | — | EODHD |
| Q3 FY2023 | 2023-05-02 | $0.29 | $0.34 | -14.7% | $245.7M | — | — | EODHD |
| Q2 FY2023 | 2023-02-07 | $0.34 | $0.30 | +13.3% | $244.6M | — | — | EODHD |
| Q1 FY2023 | 2022-11-08 | $0.21 | $0.27 | -22.2% | $232.5M | — | — | EODHD |
| Q4 FY2022 | 2022-08-23 | $0.36 | $0.38 | -5.3% | $255.3M | — | — | EODHD |
| Q3 FY2022 | 2022-05-03 | $0.33 | $0.35 | -5.7% | $239.6M | — | — | EODHD |
| Q2 FY2022 | 2022-02-08 | $0.37 | $0.33 | +12.1% | $232.7M | — | — | EODHD |
| Q1 FY2022 | 2021-11-01 | $0.25 | $0.29 | -13.8% | $214.7M | — | — | EODHD |
| Q4 FY2021 | 2021-08-24 | $0.32 | $0.31 | +3.2% | $220.3M | — | — | EODHD |
| Q3 FY2021 | 2021-05-05 | $0.34 | $0.32 | +6.3% | $211.7M | — | — | EODHD |
Source: EODHD. PAHC reported actuals as published; sparse fields render as —.
Track Record
SampleSpoken Alpha tracks PAHC's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Misses consensus 10/10 quarters
SampleRepeated misses without a guidance reset suggest management is structurally optimistic relative to operating reality. Track whether next-quarter guidance is being benchmarked off the prior miss or the prior plan.
Missed in 4 of the last 4 quarters
SampleRecent misses matter more than long-window beat rate — the trailing 12 months drives the analyst model and the next-print bar.
Quarterly beats & misses
Sample| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $1.42 | $1.78 | -20.1% | -0.4% | -0.4% |
| Q4 FY2026 | $1.56 | $1.86 | -16.2% | +0.5% | +3.1% |
| Q3 FY2026 | $1.58 | $1.94 | -18.5% | -6.8% | -9.5% |
| Q2 FY2026 | $1.46 | $1.91 | -23.6% | -0.8% | -2.9% |
| Q1 FY2025 | $1.61 | $1.88 | -14.4% | -1.2% | -1.5% |
| Q4 FY2025 | $1.31 | $1.82 | -28.2% | -5.5% | -8.4% |
| Q3 FY2025 | $1.39 | $1.83 | -24.1% | +1.0% | -0.9% |
| Q2 FY2025 | $1.58 | $1.83 | -13.9% | -3.2% | -6.1% |
| Q1 FY2024 | $1.69 | $2.05 | -17.4% | -5.1% | -2.7% |
| Q4 FY2024 | $1.52 | $1.95 | -22.1% | +1.0% | +3.5% |
Guidance change history
Sample- Q1 FY2026Lowered2026-04-15
- Q4 FY2026Lowered2026-13-15
- Q3 FY2026Lowered2026-10-15
- Q2 FY2026Lowered2026-07-15
- Q1 FY2025Lowered2025-04-15
- Q4 FY2025Lowered2025-13-15
- Q3 FY2025Lowered2025-10-15
- Q2 FY2025Lowered2025-07-15
Top executives
SampleSpoken Alpha builds an accountability record per executive — how the person's own guidance, language, and reactions have evolved across every call they've appeared on. The one-liners below are illustrative placeholder data pending the deviation v1 work. Click any name for the full role timeline and call appearance history.
- Jack BendheimCEO9 mo20 callsCurrentSample
CEO since 2025 • 3/4 beats (75%) • last guidance raise Q2 FY2026
- Glenn DavidCFO10 mo8 callsCurrentSample
CFO since 2025 • 2/4 beats (50%) • guidance suspended Q2 FY2026
- Larry Lee MillerCOO10 mono recorded callsCurrentSample
COO since 2025 • 2/4 beats (50%) • guidance suspended Q1 FY2026
- Patrick RodriguezVP Finance and Treasurer5 mono recorded callsCurrentSample
OTHER since 2026 • 1/2 beats (50%) • last call held guidance Q2 FY2026
- Judith WeinsteinSee Remarks10 mono recorded callsCurrentSample
OTHER since 2025 • 3/4 beats (75%) • last call held guidance Q2 FY2026
Peers
Other companies in Healthcare
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
For developers and AI agents
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for PAHC.
$ curl https://api.spokenalpha.com/v1/companies/PAHCFAQ
Frequently asked about PAHC
Where can I find PHIBRO ANIMAL HEALTH CORP's (PAHC) earnings call transcripts?
Spoken Alpha indexes PAHC's earnings call transcripts at https://spokenalpha.com/companies/PAHC. Each call links to attributed speakers and parsed analyst Q&A. PHIBRO ANIMAL HEALTH CORP's own investor relations page is at https://investors.pahc.com/home/default.aspx.
When was PHIBRO ANIMAL HEALTH CORP's most recent earnings call?
PHIBRO ANIMAL HEALTH CORP (PAHC) held its most recent earnings call on 2025-11-06, covering fiscal Q1 2026.
What sector is PAHC in?
PHIBRO ANIMAL HEALTH CORP (PAHC) operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).